Division of Cancer Prevention and Control; College of Medicine, The Ohio State University, Columbus, OH USA.
Hum Vaccin Immunother. 2013 Jan;9(1):90-6. doi: 10.4161/hv.22389. Epub 2012 Nov 10.
Appalachia is a geographic region with existing cancer disparities, yet little is known about its burden of HPV-related cancers outside of cervical cancer. We assessed the burden of HPV-related cancers in three Appalachian states and made comparisons to non-Appalachian regions. We examined 1996-2008 cancer registry data for Ohio, Kentucky, West Virginia and the Surveillance, Epidemiology and End Results (SEER) 9 program. For each gender, we calculated age-adjusted incidence rates per 100,000 population for each HPV-related cancer type (cervical, vaginal, vulvar, penile, anal and oral cavity and pharyngeal cancers) and all HPV-related cancers combined. Incidence rates among females for all HPV-related cancers combined were higher in Appalachian Kentucky [24.6 (95% CI: 23.5-25.7)], West Virginia [22.8 (95% CI: 22.0-23.6)] and Appalachian Ohio [21.9 (95% CI: 21.0-22.8)] than SEER 9 [18.8 (95% CI: 18.6-19.0)]. Similar disparities were found among females when examining cervical and vulvar cancers separately. Among males, Appalachian [21.3 (95% CI: 20.2-22.4)] and non-Appalachian [21.9 (95% CI: 21.2-22.7)] Kentucky had higher incidence rates for all HPV-related cancers combined than SEER 9 [18.3 (95% CI: 18.1-18.6)]. The incidence rate of all HPV-related cancers combined was higher among males from Appalachian Ohio compared with those from non-Appalachian Ohio [17.6 (95% CI: 16.8-18.5) vs. 16.3 (95% CI: 16.0-16.6)]. Our study suggests that HPV-related cancer disparities exist in Appalachia beyond the known high cervical cancer incidence rates. These results have important public health implications by beginning to demonstrate the potential impact that widespread HPV vaccination could have in Appalachia.
阿巴拉契亚地区存在癌症差异,尽管如此,对于该地区以外的 HPV 相关癌症的了解却很少。我们评估了三个阿巴拉契亚州 HPV 相关癌症的负担,并与非阿巴拉契亚地区进行了比较。我们研究了俄亥俄州、肯塔基州、西弗吉尼亚州 1996-2008 年的癌症登记数据和监测、流行病学和最终结果(SEER)9 计划。对于每个性别,我们计算了每 10 万人中每种 HPV 相关癌症类型(宫颈癌、阴道癌、外阴癌、阴茎癌、肛门癌和口腔癌和咽癌)以及所有 HPV 相关癌症的年龄调整发病率。阿巴拉契亚地区肯塔基州(24.6[95%CI:23.5-25.7])、西弗吉尼亚州(22.8[95%CI:22.0-23.6])和俄亥俄州(21.9[95%CI:21.0-22.8])女性中所有 HPV 相关癌症的综合发病率均高于 SEER 9(18.8[95%CI:18.6-19.0])。在分别检查宫颈癌和外阴癌时,女性中也发现了类似的差异。对于男性,阿巴拉契亚地区(21.3[95%CI:20.2-22.4])和非阿巴拉契亚地区(21.9[95%CI:21.2-22.7])的肯塔基州所有 HPV 相关癌症的综合发病率均高于 SEER 9(18.3[95%CI:18.1-18.6])。与非阿巴拉契亚俄亥俄州相比,阿巴拉契亚俄亥俄州男性所有 HPV 相关癌症的发病率更高[17.6(95%CI:16.8-18.5)vs.16.3(95%CI:16.0-16.6)]。我们的研究表明,阿巴拉契亚地区 HPV 相关癌症的差异不仅存在于已知的高宫颈癌发病率,而且还存在于其他地方。这些结果具有重要的公共卫生意义,因为它们开始展示广泛的 HPV 疫苗接种可能在阿巴拉契亚地区产生的潜在影响。